Chemotargets CLARITY® enables global profiling for a given set of molecules: quantitative binding and functional activity for mechanisms of action associated with therapeutic activities and safety liabilities, a full range of toxicity, adverse events & ADME parameters and predicted metabolites and their pharmacological profiles, and comparison with substrates.
Chemotargets Clarity is used by Drug R&D professionals worldwide to:
Uncover drug discovery opportunities:
Assess the safety profile of drugs & identify off-target liabilities
Identify safety issues associated with metabolites
Founded on March 2006 as a spin-off from Dr. Mestres’ Systems Pharmacology lab at IMIM, Chemotargets is currently recognized as a global leader in the provision of predictive analytics solutions to pharmaceutical and biotechnology companies and research institutions.
Chemotargets Clarity's Predictive Performance is a result of the company's solid scientific background, multiple peer-reviewed publications and project track record.
Chemotargets CLARITY platform’s architecture offers a fully interoperable environment that can be integrated with your infrastructure via command line.